- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
**1. Financial Highlights:**
Bodal Chemicals reported strong Q1 financial results. Revenue rose 8% YoY to Rs. 458.3 Cr, with EBITDA surging 40% YoY to Rs. 51.7 Cr. PAT turned profitable at Rs. 9.5 Cr, reversing previous losses. EBITDA margin significantly improved to 11.3%. Basic Chemicals revenue saw robust growth.
**2. Strategic Initiatives & Growth Drivers:**
The Saykha Benzene downstream project has begun normal production, now contributing to topline with expectations for sequential improvement. The Chlor Alkali business anticipates sturdy performance due to steady demand. Future growth will be driven by new client outreach, enhanced integration, and capacity expansions.
**3. Business Developments:**
Bodal's Chinese and Indonesian subsidiaries performed satisfactorily. Chlor Alkali revenue grew 8% YoY.
**4. Market Position & Competitive Advantage:**
As an integrated chemical player, Bodal benefits from a diversified product portfolio and global presence, with 25% revenue from exports. Its integrated business model provides cost advantages. The company's strong environmental compliance and strategic positioning leverage India's "China+1" opportunity.
**5. Investor Implications:**
The Q1 profitability turnaround and initial contributions from the Saykha project signal positive growth potential. Bodal's integrated model and strategic focus on capacity ramp-up appear favorable for sustained performance.